Nurix Therapeutics Correlations

NRIX Stock

USD 12.99 0.88 6.34%

The current 90-days correlation between Nurix Therapeutics and Monte Rosa Therapeutics is 0.58 (i.e., Very weak diversification). The correlation of Nurix Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Nurix Therapeutics Correlation With Market

Weak diversification

The correlation between Nurix Therapeutics and DJI is 0.38 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Nurix Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nurix Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Nurix Stock please use our How to Invest in Nurix Therapeutics guide.

Moving together with Nurix Stock

0.82	CDIOW	Cardio Diagnostics	Pair Corr
0.71	ELVN	Enliven Therapeutics	Pair Corr
0.86	SCLX	Scilex Holding	Pair Corr
0.84	ASMB	Assembly Biosciences Earnings Call This Week	Pair Corr
0.73	CMND	Clearmind Medicine Common	Pair Corr
0.67	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.8	CAT	Caterpillar	Pair Corr
0.76	HD	Home Depot	Pair Corr
0.74	DIS	Walt Disney	Pair Corr
0.91	MSFT	Microsoft	Pair Corr

Moving against Nurix Stock

0.83	LUCD	Lucid Diagnostics	Pair Corr
0.73	WM	Waste Management	Pair Corr
0.53	GE	GE Aerospace	Pair Corr
0.52	PG	Procter Gamble	Pair Corr
0.36	PLX	Protalix Biotherapeutics	Pair Corr
0.89	JNJ	Johnson Johnson	Pair Corr
0.85	T	ATT Inc Earnings Call Tomorrow	Pair Corr
0.6	IBM	International Business	Pair Corr
0.58	CVX	Chevron Corp	Pair Corr
0.57	XOM	Exxon Mobil Corp	Pair Corr
0.56	INTC	Intel	Pair Corr
0.55	MMM	3M Company	Pair Corr
0.48	CSCO	Cisco Systems	Pair Corr

Related Correlations Analysis

	FHTX	STTK	GLUE	KYMR	CCCC	ARVN	ELYM	PRLD	RLAY	STOK
FHTX		0.17	0.4	-0.01	0.12	0.27	0.0	-0.07	-0.05	0.14	FHTX
STTK	0.17		-0.21	-0.31	-0.29	0.02	0.0	-0.2	-0.23	-0.31	STTK
GLUE	0.4	-0.21		0.26	0.29	0.09	0.0	0.23	0.16	0.62	GLUE
KYMR	-0.01	-0.31	0.26		0.88	0.52	0.0	0.79	0.89	0.7	KYMR
CCCC	0.12	-0.29	0.29	0.88		0.75	0.0	0.8	0.86	0.75	CCCC
ARVN	0.27	0.02	0.09	0.52	0.75		0.0	0.61	0.61	0.49	ARVN
ELYM	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	ELYM
PRLD	-0.07	-0.2	0.23	0.79	0.8	0.61	0.0		0.77	0.68	PRLD
RLAY	-0.05	-0.23	0.16	0.89	0.86	0.61	0.0	0.77		0.71	RLAY
STOK	0.14	-0.31	0.62	0.7	0.75	0.49	0.0	0.68	0.71		STOK
	FHTX	STTK	GLUE	KYMR	CCCC	ARVN	ELYM	PRLD	RLAY	STOK

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

RLAY	+ 0.89	KYMR
CCCC	+ 0.88	KYMR
RLAY	+ 0.86	CCCC
PRLD	+ 0.8	CCCC
PRLD	+ 0.79	KYMR
RLAY	+ 0.77	PRLD

High negative correlations

STOK	- 0.31	STTK
KYMR	- 0.31	STTK
CCCC	- 0.29	STTK
RLAY	- 0.23	STTK
GLUE	- 0.21	STTK
PRLD	- 0.2	STTK

Risk-Adjusted Indicators

There is a big difference between Nurix Stock performing well and Nurix Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Nurix Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
FHTX	3.69	(0.16)	0.00	(0.15)	0.00	0.00	9.05	(7.58)	26.22
STTK	5.19	0.37	0.05	0.49	6.40	(6.46)	11.21	(7.58)	50.15
GLUE	3.56	(0.22)	0.00	(0.26)	0.00	0.00	7.34	(7.69)	19.92
KYMR	2.84	(0.23)	0.00	(0.23)	0.00	0.00	5.50	(7.08)	23.03
CCCC	3.36	(0.84)	0.00	(0.39)	0.00	0.00	6.86	(7.76)	19.46
ARVN	3.70	(0.66)	0.00	(0.33)	0.00	0.00	5.93	(6.05)	61.27
ELYM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PRLD	5.41	0.28	0.03	0.05	5.73	(6.74)	12.50	(9.46)	61.66
RLAY	4.18	(0.40)	0.00	(0.27)	0.00	0.00	6.27	(7.87)	26.72
STOK	3.45	(0.39)	0.00	(0.32)	0.00	0.00	7.03	(9.08)	20.29

Nurix Therapeutics Corporate Management

Stefani Wolff	COO Devel	Profile
Christopher Phelps	Senior Discovery	Profile
Christine JD	Secretary Officer	Profile
John Kuriyan	Founder Board	Profile
JD Esq	VP Counsel	Profile
Cristiana Guiducci	Senior Research	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC